CN1262110A - Medicine for treating pain of lumbus, leg, neck and shoulder - Google Patents
Medicine for treating pain of lumbus, leg, neck and shoulder Download PDFInfo
- Publication number
- CN1262110A CN1262110A CN 99100582 CN99100582A CN1262110A CN 1262110 A CN1262110 A CN 1262110A CN 99100582 CN99100582 CN 99100582 CN 99100582 A CN99100582 A CN 99100582A CN 1262110 A CN1262110 A CN 1262110A
- Authority
- CN
- China
- Prior art keywords
- medicine
- parts
- rhizoma
- radix
- skelalgia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 41
- 208000002193 Pain Diseases 0.000 title abstract description 15
- 229940079593 drug Drugs 0.000 title description 5
- 239000002775 capsule Substances 0.000 claims abstract description 9
- 241000218176 Corydalis Species 0.000 claims abstract description 8
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 8
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 8
- 208000008035 Back Pain Diseases 0.000 claims description 26
- 208000008930 Low Back Pain Diseases 0.000 claims description 24
- 206010028391 Musculoskeletal Pain Diseases 0.000 claims description 12
- 206010028836 Neck pain Diseases 0.000 claims description 12
- 208000007613 Shoulder Pain Diseases 0.000 claims description 12
- 241000903946 Clematidis Species 0.000 claims description 7
- 241001489978 Eupolyphaga Species 0.000 claims description 7
- 241000522620 Scorpio Species 0.000 claims description 7
- 239000009490 scorpio Substances 0.000 claims description 7
- 241000237903 Hirudo Species 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 4
- 235000005903 Dioscorea Nutrition 0.000 claims description 3
- 241000234273 Dioscorea Species 0.000 claims description 3
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 3
- 241000202807 Glycyrrhiza Species 0.000 claims description 3
- 241001180876 Saposhnikovia Species 0.000 claims description 3
- 235000004879 dioscorea Nutrition 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 241000545744 Hirudinea Species 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 238000000034 method Methods 0.000 abstract description 5
- 235000015655 Crocus sativus Nutrition 0.000 abstract 1
- 244000124209 Crocus sativus Species 0.000 abstract 1
- 241000229179 Ledebouriella Species 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 235000013974 saffron Nutrition 0.000 abstract 1
- 239000004248 saffron Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 8
- 230000001225 therapeutic effect Effects 0.000 description 7
- 235000012054 meals Nutrition 0.000 description 6
- 206010005963 Bone formation increased Diseases 0.000 description 5
- 206010003246 arthritis Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 206010050031 Muscle strain Diseases 0.000 description 3
- 208000001132 Osteoporosis Diseases 0.000 description 3
- 208000031481 Pathologic Constriction Diseases 0.000 description 3
- 208000012287 Prolapse Diseases 0.000 description 3
- 208000026137 Soft tissue injury Diseases 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 238000003303 reheating Methods 0.000 description 3
- 230000036262 stenosis Effects 0.000 description 3
- 208000037804 stenosis Diseases 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 241000305492 Gastrodia Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000003041 ligament Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 210000000323 shoulder joint Anatomy 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- 206010008334 Cervicobrachial syndrome Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 208000007875 Femur Head Necrosis Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 206010037779 Radiculopathy Diseases 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000025720 ankylosing spondylitis 1 Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 206010061928 radiculitis Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 208000005198 spinal stenosis Diseases 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A medicine in the form of capsules or particles for treating the pain of lumbus, leg, neck and shoulder is prepared from 15 Chinse-medicinal materials including scorpion, saffron, notoginseng, corydalis tuber, ledebouriella root, etc through conventional process. Its advantages are high curative effect and unique prescription.
Description
The present invention relates to a kind of medicine for the treatment of lumbago and skelalgia, this medicine can also be treated neck and shoulder pain, specifically is the Chinese patent medicine of feedstock production with the Chinese herbal medicine.
Lumbago and skelalgia (pain in low back and legs) is meant the pathological changes of waist muscle, lumbar vertebra, tendon, joint, ligament, causes that lumbago or lower limb produce radiated pain.The congenital textural anomaly of the wound of waist, inflammation, tumor, osteoporosis and lumbar vertebra all can cause lumbago and skelalgia.It shows as the restriction of waist active receiving, local tenderness and emits to lower limb and makes handicapped.Doctor trained in Western medicine thinks that lumbago and skelalgia mainly is to be caused by the inflammation of prolapse of lumbar intervertebral disc, the strain of waist hip soft tissue, osteoporosis, spinal stenosis and vertebra or spinal cord, tumor, radiculitis etc.In " interior warp " existing lumbago and and lumbago relate to the record of position pain such as the back of the body, sacrum, buttocks, lower limb, motherland's medical science thinks that primary disease is to suffer from a deficiency of the kidney and being invaded by exogenous pathogen, fall to wink and frustrate and cause.
Neck and shoulder pain (neck and shoulder pain) by a kind of common syndrome that neck bone, joint, ligament, muscle, fascia and shoulder joint soft tissue lesions or viscera disease cause, claim cervicobrachialgia again.Show as local pain.Because of the complex structure of neck and shoulder part, relation is close again between neural blood vessel, so cause that the factor of neck and shoulder pain is also a lot.Motherland's medicine is classified as it category of " arthromyodynia ".
At present, the Chinese patent medicine that is used for the treatment of acute and chronic lumbago and skelalgia, neck and shoulder pain mainly contains XIAOHUOLUO WAN and restorative bolus, above-mentioned two kinds of its doses of Chinese patent medicine are excessive, medicine time is long and difficulty can be cured above-mentioned disease, though what have can cure, but the compound recipe rate is very high, especially the patient will be through in a few years even the treatment of decades, and financial burden is heavy, stands the inconvenience of taking medicine for a long time and bringing again.Chinese patent CN 1194850A discloses a kind of medicine for the treatment of hyperosteogeny, lumbago and skelalgia, but still have that complicated process of preparation, cost of drugs are higher, weak point is cut or the like in uncertain therapeutic efficacy; Chinese patent CN 1083720A discloses a kind of treatment because of caused neck and shoulder pain of rheumatism, strain or hypertrophy and " Lingdan " moxibustion plaster, exists equally that complicated process of preparation, cost of drugs are higher, weak point is cut or the like in uncertain therapeutic efficacy;
The object of the present invention is to provide a kind of pure natural medical for the treatment of the lumbago and skelalgia that rheumatic arthritis, arthritis, cervical vertebra, lumbar vertebra hyperosteogeny, ankylosing spondylitis, prolapse of lumbar intervertebral disc, lumbar muscle strain, numb limbs and tense tendons, sciatica and a variety of causes cause.
Another object of the present invention be to provide a kind of can treat lumbago and skelalgia also can treatment of arthritis, the medicine of the neck and shoulder pain that causes such as hyperosteogeny of cervical vertebra, soft tissue injury.
Solution of the present invention is based on motherland's medical science to pathogenetic understanding of lumbago and skelalgia and Therapeutic Principle, and by the handed down from the older generations of the family treatment lumbago and skelalgia of Wei Shi secret recipe, in conjunction with modern scientific theory, selected natural Chinese medicinal herb develops meticulously by the theory of Chinese medical science prescription.
Use Drug therapy lumbago and skelalgia of the present invention, neck and shoulder pain, determined curative effect, short treating period, cure rate high and more the back be difficult for recurrence, taking convenience, preparation technology are simple, with low cost.
The present invention makes (consumption is a weight portion) by following component:
Scorpio 10-20 part Stigma Croci 20-40 part Radix Notoginseng 10-25 part Rhizoma Corydalis 10-25 part Hirudo 5-10 part Radix Saposhnikoviae 5-15 part Rhizoma Gastrodiae 10-25 part Carapax et Plastrum Testudinis 20-40 part Radix Clematidis 10-25 part Caulis Spatholobi 20-40 part Rhizoma Dioscoreae 20-40 part Rhizoma Cibotii 10-25 part eupolyphaga 10-20 part Herba Lycopodii 10-20 part Radix Glycyrrhizae 5-10 part
The formula optimization weight proportion scope of preparation medicine of the present invention is:
Scorpio 10-15 part Stigma Croci 25-35 part Radix Notoginseng 10-20 part Rhizoma Corydalis 10-20 part Hirudo 5-8 part Radix Saposhnikoviae 5-10 part Rhizoma Gastrodiae 10-20 part Carapax et Plastrum Testudinis 25-35 part Radix Clematidis 10-20 part Caulis Spatholobi 25-35 part Rhizoma Dioscoreae 25-35 part Rhizoma Cibotii 10-20 part eupolyphaga 10-15 part Herba Lycopodii 10-15 part Radix Glycyrrhizae 5-8 part
The optimum weight proportioning of medicine of the present invention is:
6 parts in 12 portions of Radix Glycyrrhizaes of 12 parts of Herba Lycopodiis of 15 parts of eupolyphaga of 30 parts of Rhizoma Cibotii of 30 portions of Rhizoma Dioscoreaes of 15 portions of Caulis Spatholobis of 30 parts of Radix Clematidis of 15 parts of Carapax et Plastrum Testudiniss of 10 parts of Rhizoma Gastrodiaes of 6 parts of Radix Saposhnikoviaes of 15 portions of Hirudoes of 15 parts of Rhizoma Corydalis of 30 portions of Radix Notoginseng of 12 parts of Stigma Crocis of Scorpio
Above-mentioned each component is pulverized, crosses 100 mesh sieves, boiled twice before adding water, add 10 times of amounts of water for the first time, decocted 3 hours; For the second time add 8 times of amounts of water, decocted 2 hours, collecting decoction staticly settles, and gets supernatant, concentrates thick paste (survey is generally 1.30～1.35 than reheating), and drying is prepared into granule, packing, every bag of weight 12g according to the preparation method of Chinese medicine granules routine.
Medicine of the present invention also can will be prepared into capsule.Above-mentioned each component is pulverized, crosses 100 mesh sieves, boiled twice before adding water, add 10 times of amounts of water for the first time, decocted 3 hours; For the second time add 8 times of amounts of water, decocted 2 hours, collecting decoction staticly settles, and gets supernatant, concentrates thick paste (survey is generally 1.30～1.35 than reheating), and drying is prepared into capsule, packing, every capsules weight 400mg according to the preparation method of Chinese medicinal capsule agent routine.
Clinical use result shows that medicine of the present invention has following advantage:
1. medicine expelling wind and removing dampness of the present invention, promoting blood circulation to remove obstruction in the collateral, anti-inflammatory analgesic, treatment lumbago and skelalgia determined curative effect, short treating period, the high and more difficult recurrence in back of cure rate.
2. drug administration of the present invention is convenient, preparation technology is simple, with low cost.
3. medicine of the present invention also can be used for the neck and shoulder pain that treatment of arthritis, hyperosteogeny of cervical vertebra, soft tissue injury etc. cause.
For showing the therapeutic effect of medicine of the present invention to lumbago and skelalgia, the present invention is through the clinical observation of 120 routine systems, and patient's 30 examples of selection medical history, the state of an illness, sex, age patient 75 examples and former medication in contrast, and clinical data is as follows.
1 clinical data
1.1 physical data: observation group's 75 examples, wherein male's 40 examples, women's 35 examples; Minimum 23 years old of age, maximum 80 years old; The course of disease is the shortest 2 months, year surplus in the of the longest 10.Matched group 30 examples, male's 19 examples wherein, women's 11 examples; At minimum 18 years old of age, maximum 78 years old, the course of disease was the shortest 3 months, year surplus in the of the longest 10.
1.2 clinical diagnosis: prolapse of lumbar intervertebral disc 58 examples are arranged in 75 examples, person's 4 examples of wherein accompanying the spinal canal stenosis, companion's osteoporosis 2 examples, intervertebral disc marrow nuclear excising postoperative recurrence 1 example, the percutaneous puncture intervertebral disc is cut and is inhaled postoperative recurrence 1 example; Spinal canal stenosis 2 examples; Lumbar degenerative arthritis 9 examples, acute lumbar muscle sprain 3 examples; Ischemic necrosis of femoral head 2 examples; Ankylosing spondylitis 1 example.Matched group middle part of the side intercolumniation disc protrusion 26 examples, person's 4 examples of wherein accompanying the spinal canal stenosis; Lumbar degenerative pathological changes 1 example; Lumbar vertebra back joint disorder 2 examples; Lumbar muscle strain 1 example.
2 criterions of therapeutical effect
Cure: lumbago and skelalgia disappears, and movable the recovery normally can be participated in normal work or physical labor, and it is negative that special examined mostly is; Produce effects: lumbago and skelalgia disappears substantially, and is movable approaching normal, can participate in lighter physical work, and the special examined major part is negative; Take a turn for the better: lumbago and skelalgia alleviates, and movable part improves, and can participate in suitable physical work, and special examined has improvement before the treatment; Invalid: through the treatment of 2 courses of treatment, symptom does not have obvious improvement.
3 Therapeutic Method
3.1 observation group: pharmaceutical composition of the present invention, an oral 2-3 grain, 3 times on the one, taking medicine after meal.Treat to change the 2-3 grain into after pain disappearance, the remission, a twice-daily is kept sooner or later after meal, and 3 months is a course of treatment.
3.2 matched group: XIAOHUOLUO WAN.One time 1 ball, 2 times on the one, with yellow wine or warm water delivery service (one one of Pharmacopoeia of the People's Republic of China nineteen ninety-five version).
4 observed results
Table 1
The example number is cured (%) produce effects (%) improvement (%) invalid (%) total effective rate observation group 75 26 (34.67 28 (37.33 16 (21.33 5 (6.67%) 93.33%
%) %) %) matched group 30 3 (10%) 15 (50%) 9 (30%) 3 (10%) 90%
Learn by statistics and handle: H=4.1269, P＜0.05, the result shows that observation group's total effective rate is better than matched group, there were significant differences.
We have also observed the therapeutic effect of the neck and shoulder pain that medicine of the present invention causes arthritis, hyperosteogeny of cervical vertebra, soft tissue injury etc.
1 clinical data
1.1 physical data:
This group patient 298 examples, wherein male 241 examples, women 84 examples, men and women's ratio is 2.55: 1,43 examples of person below 30 years old, 30～39 years old person's 105 example, 40～49 years old person's 86 example, 50～59 years old person's 41 example, 60～63 years old person's 23 example.
1.2 case choice criteria:
All patients' shoulder joint X sheet, erythrocyte sedimentation rate, anti-" O ", hemogram are all normal.
2 criterions of therapeutical effect:
Cure: the neck distending pain, take on all severe pain, moving obstacle complete obiteration, can participate in normally and work, special examined mostly is feminine gender; Produce effects: the neck distending pain, take on all severe pain, moving obstacle disappears substantially, movable can participate in lighter physical work near normal, the special examined major part is negative; Take a turn for the better: the neck distending pain alleviates, take on and still has dull pain or mobility more normally to reduce in week, and special examined has improvement before treating; Invalid: through the treatment of 2 courses of treatment, symptom does not have obvious improvement.
3 Therapeutic Method
3.1 observation group: pharmaceutical composition of the present invention, an oral 2-3 grain, 3 times on the one, taking medicine after meal.Treat to change the 2-3 grain into after pain disappearance, the remission, a twice-daily is kept sooner or later after meal, and 3 months is a course of treatment.
3.2 matched group: XIAOHUOLUO WAN.One time 1 ball, 2 times on the one, with yellow wine or warm water delivery service (one one of Pharmacopoeia of the People's Republic of China nineteen ninety-five version).
4 observed results
Table 2
The example number is cured (%) produce effects (%) improvement (%) invalid (%) total effective rate observation group 186 64 (34.4%) 83 (44.6%) 30 (16.1%) 11 (5.9%) 94.1% matched groups 112 22 (19.6%) 37 (33.1%) 25 (22.3%) 28 (25%) 75%
Use the Ridit analytic process, the t method of inspection carries out statistical analysis, and significant difference is arranged between the two, and treatment group curative effect is better than matched group, P＜0.05.
Following embodiment is detailed description of the present invention, is not in the present invention is limited to.
Embodiment
Take by weighing raw material by following proportioning:
6 parts in 12 portions of Radix Glycyrrhizaes of 12 parts of Herba Lycopodiis of 15 parts of eupolyphaga of 30 parts of Rhizoma Cibotii of 30 portions of Rhizoma Dioscoreaes of 15 portions of Caulis Spatholobis of 30 parts of Radix Clematidis of 15 parts of Carapax et Plastrum Testudiniss of 10 parts of Rhizoma Gastrodiaes of 6 parts of Radix Saposhnikoviaes of 15 portions of Hirudoes of 15 parts of Rhizoma Corydalis of 30 portions of Radix Notoginseng of 12 parts of Stigma Crocis of Scorpio
Production method is as follows:
Above-mentioned each component is pulverized, crosses 100 mesh sieves, boiled twice before adding water, add 10 times of amounts of water for the first time, decocted 3 hours; For the second time add 8 times of amounts of water, decocted 2 hours, collecting decoction staticly settles, and gets supernatant, concentrates thick paste (survey is generally 1.30～1.35 than reheating), and drying is prepared into capsule, packing, every capsules weight 400mg according to the preparation method of Chinese medicinal capsule agent routine.
Usage and consumption: an oral 2-3 grain, 3 times on the one, taking medicine after meal.Treat to change the 2-3 grain into after pain disappearance, the remission, a twice-daily is kept sooner or later after meal.Child dose below 10 years old reduces by half or follows the doctor's advice.General 3 months is a course of treatment.Gastric and duodenal ulcers and anemia of pregnant woman's forbidding.
Claims (7)
1. medicine for the treatment of lumbago and skelalgia is characterized in that it is the medicament of being made by the following weight proportion raw material:
Scorpio 10-20 part Stigma Croci 20-40 part Radix Notoginseng 10-25 part Rhizoma Corydalis 10-25 part ant
Leech 5-10 part Radix Saposhnikoviae 5-15 part Rhizoma Gastrodiae 10-25 part Carapax et Plastrum Testudinis 20-40 part Radix Clematidis
10-25 part Caulis Spatholobi 20-40 part Rhizoma Dioscoreae 20-40 part Rhizoma Cibotii 10-25 part eupolyphaga
10-20 part Herba Lycopodii 10-20 part Radix Glycyrrhizae 5-10 part
2. the medicine of the described treatment lumbago and skelalgia of claim 1, wherein the weight proportion of each raw material is
Scorpio 10-15 part Stigma Croci 25-35 part Radix Notoginseng 10-20 part Rhizoma Corydalis 10-20 part ant
Leech 5-8 part Radix Saposhnikoviae 5-10 part Rhizoma Gastrodiae 10-20 part Carapax et Plastrum Testudinis 25-35 part Radix Clematidis
10-20 part Caulis Spatholobi 25-35 part Rhizoma Dioscoreae 25-35 part Rhizoma Cibotii 10-20 part eupolyphaga
10-15 part Herba Lycopodii 10-15 part Radix Glycyrrhizae 5-8 part
3. the medicine of the described treatment lumbago and skelalgia of claim 1, wherein the weight proportion of each raw material is
10 parts of 6 parts of Radix Saposhnikoviaes of 15 portions of Hirudoes of 15 parts of Rhizoma Corydalis of 30 portions of Radix Notoginseng of 12 parts of Stigma Crocis of Scorpio
30 parts of Rhizoma Cibotii 15 of 30 portions of Rhizoma Dioscoreaes of 15 portions of Caulis Spatholobis of 30 parts of Radix Clematidis of 15 parts of Carapax et Plastrum Testudiniss of Rhizoma Gastrodiae
6 parts in 12 portions of Radix Glycyrrhizaes of part 12 parts of Herba Lycopodiis of eupolyphaga
4. the medicine of claim 1,2 or 3 described treatment diabetes is characterized in that said medicament is a said dosage form on any pharmaceutics.
5. the medicine of the described treatment lumbago and skelalgia of claim 4 is characterized in that said medicament is a capsule.
6. the medicine of the described treatment lumbago and skelalgia of claim 4, its feature sky is a granule in said medicament.
7. the application of the described medicine of claim 1 in the medicine of treatment neck and shoulder pain.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 99100582 CN1262110A (en) | 1999-02-04 | 1999-02-04 | Medicine for treating pain of lumbus, leg, neck and shoulder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 99100582 CN1262110A (en) | 1999-02-04 | 1999-02-04 | Medicine for treating pain of lumbus, leg, neck and shoulder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1262110A true CN1262110A (en) | 2000-08-09 |
Family
ID=5270077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 99100582 Pending CN1262110A (en) | 1999-02-04 | 1999-02-04 | Medicine for treating pain of lumbus, leg, neck and shoulder |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1262110A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001091766A3 (en) * | 2000-06-01 | 2002-09-12 | Theralife Inc | Compositions for treating hand and wrist discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
| CN101322756B (en) * | 2008-08-02 | 2011-08-31 | 曾立志 | Medicament for massaging and treating lumbar disease and preparation thereof |
| CN102600385A (en) * | 2012-03-03 | 2012-07-25 | 刘天岐 | Lycopodium clavatum pain relieving tablet |
| CN105169065A (en) * | 2015-10-11 | 2015-12-23 | 南京市栖霞区回春堂电子商务咨询中心 | Granules for treating pain in waist and lower extremities |
-
1999
- 1999-02-04 CN CN 99100582 patent/CN1262110A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001091766A3 (en) * | 2000-06-01 | 2002-09-12 | Theralife Inc | Compositions for treating hand and wrist discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
| CN101322756B (en) * | 2008-08-02 | 2011-08-31 | 曾立志 | Medicament for massaging and treating lumbar disease and preparation thereof |
| CN102600385A (en) * | 2012-03-03 | 2012-07-25 | 刘天岐 | Lycopodium clavatum pain relieving tablet |
| CN105169065A (en) * | 2015-10-11 | 2015-12-23 | 南京市栖霞区回春堂电子商务咨询中心 | Granules for treating pain in waist and lower extremities |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101703692A (en) | Chinese medicinal preparation for treating bone fracture and preparation method thereof | |
| CN1539479A (en) | Drug for curing disease of proplapse of lumbar intervertebral disc | |
| CN1124156C (en) | Chinese-medicinal pills for treating rheumatism and preparing process thereof | |
| CN1235630C (en) | Chinese medicine paste for curing osteoarthropathy and preparing method | |
| CN109172770A (en) | Facilitate the herbal composite and preparation method thereof of uric acid adjusting | |
| CN101912536B (en) | Medicinal composition for treating rheumatism and rheumatoid disease | |
| CN113813347A (en) | Preparation method and process of compound paclitaxel anti-tumor capsule tablet | |
| CN1262110A (en) | Medicine for treating pain of lumbus, leg, neck and shoulder | |
| CN1270053A (en) | Medicine for treating rheumatic arthritis and hyperosteogeny and preparing process thereof | |
| CN1186067C (en) | Medicine for curing acute injury of muscle and tendon and its preparation method | |
| CN116531409A (en) | Vein relaxing and pain relieving ointment and preparation method thereof | |
| CN108310217A (en) | Zhuanggu medicinal liquor and production method | |
| CN1183986A (en) | Chinese medicine Pingguxiaociwan for curing Bi-syndrome | |
| CN105688059A (en) | A kind of traditional Chinese medicine preparation containing mugwort leaf for external application to treat hyperosteogeny | |
| CN1843421A (en) | Rheumatoid disease treating medicine | |
| CN103041362A (en) | Drug for treating rheumatism and rheumatoid and preparation method thereof | |
| CN109908307A (en) | For treating the drug and preparation method thereof of lumber ertebral disc, rheumatic and rheumatoid | |
| CN109432309A (en) | Chinese medicine composition, exterior-applied medical wine and its preparation method and application | |
| CN1238013C (en) | Myocarditis treating Chinese medicine prepn | |
| CN1216617C (en) | Medicine for curing aseptic necrosis of head of femur | |
| CN1864735A (en) | A Chinese medicine for treating hyperosteogeny and preparation method thereof | |
| CN1319559C (en) | Pharmaceutical composition for treating muscle and bone pain and preparation method thereof | |
| CN107281444B (en) | Analgesic pharmaceutical composition and preparation method and application thereof | |
| CN117180395A (en) | Traditional Chinese medicine compound for treating lumbar disc herniation and axial type spinal arthritis and preparation method and application thereof | |
| CN104524152A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |